14158 Results (Page 457 of 567)
All Market Research Reports
South Korea Neurology Devices Market Analysis
South Korea Neurology Device Market size is at around $184.41 Mn in 2022 and is projected to reach $362.07 Mn in 2030, exhibiting a CAGR of 8.8% during the forecast period. With the current rates of prevalence of neurological diseases like stroke, Parkinson’s disease, Multiple Sclerosis, and Epilepsy the demand for neurology devices has also surged. Currently, international players like Boston Scientific, Medtronic, and Stryker dominate the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
UAE Neurology Devices Market Analysis
UAE Neurology Device Market size is at around $63.11 Mn in 2022 and is projected to reach $123.92 Mn in 2030, exhibiting a CAGR of 8.3% during the forecast period. Aspiring to be the center of medical excellence in surgical and non-invasive interventions in the gulf region the increasing prevalence of neurological diseases drive the demand. Major players like Abu Dhabi Medical Devices Company, Atlas Medical Group, Al Naghi Medical, and Kiwi Medical Supplies are giants in neurology devices. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
Turkey Home Healthcare Market Analysis
The Turkey home healthcare market was valued at $2.9 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.43% from 2022 to 2030 and will reach $5.54 Bn in 2030. One of the main reasons propelling the growth of this market is due to increase in chronic disease, and the aging population. The market is segmented by component and product. Some key players in this market are Turkish Cypriot Homecare, Care in Turkey, Turkey Home care, and Sağlık Garanti Home healthcare.
Kuwait Home Healthcare Market Analysis
The Kuwait home healthcare market was valued at $1.45 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $2.67 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by service and product. Some key players in this market are Bait Care, Royale Home Health, AL SAFWA HOME CARE, AbsKwt – Kuwait Home Healthcare Services, MHC care, and Dar Al Shifa Home Care among others
Kenya Home Healthcare Market Analysis
The Kenya home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by indication and product. Some key players in this market are On-Call Home Care, Crystal Homecare Kenya, Pro-Care Health Kenya, Go Care, Crystal Homecare, and others.
US Neurology Devices Market Analysis
The US Neurology Device Market size is at around $5.31 Bn in 2022 and is projected to reach $8.32 Bn in 2030, exhibiting a CAGR of 5.8% during the forecast period. With increasing emphasis on minimally invasive procedures and revolutionary research being focussed on Neurology diseases like ALS, Alzheimer’s disease, and traumatic Neurology impairment. Major players like Medtronic, GE Healthcare, and Siemens Healthineers are capturing a wider network of stakeholders. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
Nigeria Electronic Health Records Market Analysis
The Nigeria Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market is growing due to EHRs improving the quality of care by reducing medical errors, improving patient safety, and increasing efficiency in the healthcare delivery process. The market is segmented by product, application, and end User. Some of the major players are Allscripts, McKesson, Meditech, and others.
Morocco Electronic Health Records Market Analysis
The Morocco Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. Morocco's EHR market growth is due to Government initiatives to modernize the healthcare system and improve patient care. The market is segmented, by application type, and end user. The key market players are Softline, Medos, Allscripts, Cerner, and others.
Mexico Electronic Health Records Market Analysis
The Mexico Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market is segmented, by application type, and end user. The Mexican government and private sector have been investing in healthcare infrastructure, including the implementation of EHR systems. This investment is expected to continue, driving growth in the EHR market. The key market players are Softline, Medos, Allscripts, Cerner, and others.
Libya Electronic Health Records Market Analysis
The Libya Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market is segmented by product type, application type, and end user. The Libya EHR market will grow due to the growing need for efficient and cost-effective healthcare delivery and the increasing adoption of telemedicine. The key market players are Cerner Corporation, Allscripts, McKesson Corporation, and others.
Venezuela Cancer Pain Management Market Analysis
Venezuela's Cancer Pain Management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The main factors driving the growth would be the aging population, increasing cancer incidence, and the government's growing emphasis on enhancing healthcare. The market is segmented by drug type and by disease. Some of the major players include Johnson and Johnson, Grunenthal Pharma, Abbott, and Sanofi.
UAE Cancer Pain Management Market Analysis
The UAE Cancer Pain Management market is projected to grow from $32.6 Mn in 2022 to $53.15 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-2030. The main factors driving the growth would be the increasing incidence of cancers, growing awareness, advanced healthcare infrastructure, and government support. The market is segmented by drug type and by disease. Some of the major players include Neopharma (ARE), NewBridge Pharmaceuticals (ARE), Abbott, Pfizer, and Johnson & Johnson.
Spain Cancer Pain Management Market Analysis
Spain's Cancer Pain Management market is projected to grow from $125.84 Mn in 2022 to $176.23 Mn by 2030, registering a CAGR of 4.3% during the forecast period of 2022-2030. The main factors driving the growth would be government support, the aging population, and increasing cancer incidence. The market is segmented by drug type and by disease. Some of the major players include Esteve, Grunenthal Pharma, Pfizer, Teva Pharmaceuticals, and Abbott.
Italy Cancer Pain Management Market Analysis
Italy's Cancer Pain Management market is projected to grow from $156.48 Mn in 2022 to $227.69 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022-2030. The main factors driving the growth would be technological developments in pain management methods and government initiatives. The market is segmented by drug type and by disease. Some of the major players include Molteni Farmaceutici (ITA), Italfarmaco (ITA), Grunenthal Pharma, Pfizer, and Abbott.
Ireland Cancer Pain Management Market Analysis
Ireland's Cancer Pain Management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The main factors driving the growth would be aging populations, government support and initiatives, rising cancer incidences, and rising demand for pain management solutions. The market is segmented by drug type and by disease. Some of the major players include Endo International (IRL), Medtronic (IRL), Grunenthal Pharma, Pfizer, Teva Pharmaceuticals, and Abbott.
Global Cancer Pain Management Market Analysis
The global Cancer Pain Management market is projected to grow from $6.52 Bn in 2022 to $9.86 Bn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-2030. The main factors driving the growth would be the aging population, rising cancer prevalence, rising healthcare costs, and rising R&D spending by various healthcare businesses. The market is segmented by drug type and by disease. Some of the major players include Aoxing Pharmaceutical, Pfizer, Grunenthal Pharma, Teva Pharmaceutical, Hisamitsu Pharmaceutical, Sanofi, Daiichi Sankyo, Orexo, WEX Pharmaceuticals, and Sorrento Therapeutics.
France Cancer Pain Management Market Analysis
France's Cancer Pain Management market is projected to grow from $179.3 Mn in 2022 to $251.1 Mn by 2030, registering a CAGR of 4.3% during the forecast period of 2022-2030. The main factors driving the growth would be government support and initiatives, the aging population, and increasing cancer incidence. The market is segmented by drug type and by disease. Some of the major players include Sanofi (FRA), Ethypharm (FRA), Grunenthal Pharma, Pfizer, Teva Pharmaceuticals, and Abbott.
Finland Cancer Pain Management Market Analysis
Finland's Cancer Pain Management market is projected to grow from $13.69 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The main factors driving the growth would be a rising incidence of cancer and government support. The market is segmented by drug type and by disease. Some of the major players include Orion (FIN), Grunenthal Pharma, Sanofi, Pfizer, Teva Pharmaceuticals, and Abbott.
Europe Cancer Pain Management Market Analysis
Europe's Cancer Pain Management market is projected to grow from $1.24 Bn in 2022 to $1.7 Bn by 2030, registering a CAGR of 4.04% during the forecast period of 2022-2030. The main factors driving the growth would be an increase in cancer cases and government support and initiatives. The market is segmented by drug type and by disease. Some of the major players include Napp Pharmaceuticals, Grunenthal Pharma, Hisamitsu Pharmaceutical, Sanofi, Teva Pharmaceuticals, Abbott, and Pfizer.
China Rheumatology Drugs Market Analysis
The China Rheumatology Drugs Market is projected to grow from $4.908 Bn in 2022 to $6.873 Bn by 2030, registering a CAGR of 4.30% during the forecast period of 2022-2030. The most commonly used drugs in the treatment of rheumatic diseases include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic agents. There are a number of domestic pharmaceutical companies in China that are actively involved in the rheumatology drugs market. These companies include China National Biotec Group, Fosun Pharma, and Jiangsu Hengrui Medicine
India Rheumatology Drugs Market Analysis
The India Rheumatology Drugs Market is projected to grow from $1.110 Bn in 2022 to $1.743 Bn by 2030, registering a CAGR of 5.80% during the forecast period of 2022-2030. The Indian government is taking steps to improve access to rheumatology treatments by increasing funding for research and development, as well as implementing policies to reduce the cost of these drugs for patients. Some of the key players in the India rheumatology drugs market include Pfizer, Novartis, Johnson & Johnson, Roche, GlaxoSmithKline (GSK), Sanofi
Australia Rheumatology Drugs Market Analysis
The Australia Rheumatology Drugs Market is projected to grow from $0.733 Bn in 2022 to $1.026 Bn by 2030, registering a CAGR of 4.30% during the forecast period of 2022–2030. The Australian government plays a key role in the rheumatology drugs market through its reimbursement policies and the Pharmaceutical Benefits Scheme (PBS), which provides public funding for a range of prescription drugs, including those used to treat rheumatic diseases. In terms of market players, the Australian rheumatology drugs market is dominated by large multinational pharmaceutical companies, such as Pfizer Inc., Merck & Co., Inc., and AbbVie Inc., among others.
Italy Orphan Diseases Drugs Market Analysis
The Italy Orphan Diseases Drugs Market is projected to grow from $3.715 Bn in 2022 to $7.849 Bn by 2030, registering a CAGR of 9.80% during the forecast period of 2022-2030. It is a rapidly growing market, driven by increasing awareness of rare diseases, advances in biotechnology and genetics, and government support for the development of treatments for rare diseases. Menarini is an Italian pharmaceutical company specializing in the development and commercialization of treatments for various diseases, including treatments for rare diseases.
Hong Kong Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Hong Kong Dermatology drugs market will reach a value of $xx Mn from $27.24 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as ASLAN Pharmaceuticals, LEO Pharma, and Bright Future Pharmaceutical Laboratories Ltd. The market is driven by slow research and development, OTC, and government regulations. The dermatology drug market in Hong Kong is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Venezuela Home Healthcare Market Analysis
The Venezuela home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is an economic crisis and the aging population. The market is segmented by component and product. Some key players in this market are UEMICA home healthcare, Residencias Don Pascual, Community Health Care Agency, and Sun and Sea among others.
